Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy | MicrobiomeTrials← Back to trialsNCT04437771
Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy
RecruitingOBSERVATIONAL
Trial Details
Start: 2020-06-01Est. Completion: 2034-01-17
Enrollment target: 9 participants Locations- Hospital Infantil Universitario Niño Jesús (HIUNJ), Madrid, Spain
Other microbiome trials you might be interested in
MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United StatesEst. completion Jan 1, 2035
Fanconi Anemia
Background:
Fanconi anemia (FA) is a rare, inherited cancer syndrome. FA causes a range of physical issues. Children wi…
Bethesda, United StatesEst. completion Sep 1, 2026
Diamond Blackfan AnemiaDyskeratosis CongenitaFanconi AnemiaShwachman Diamond SyndromeInherited Bone Marrow Failure Syndrome, Aplastic Anemia
Background:
A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regardi…
Bethesda, United States